These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 10492162

  • 1. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X, Tabassi K, Williams JA.
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [Abstract] [Full Text] [Related]

  • 2. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X, Dillehay LE, Williams JR, Williams JA.
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [Abstract] [Full Text] [Related]

  • 3. Protracted exposure radiosensitization of experimental human malignant glioma.
    Williams JA, Williams JR, Yuan X, Dillehay LE.
    Radiat Oncol Investig; 1998 Jun; 6(6):255-63. PubMed ID: 9885941
    [Abstract] [Full Text] [Related]

  • 4. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA, Dillehay LE, Tabassi K, Sipos E, Fahlman C, Brem H.
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [Abstract] [Full Text] [Related]

  • 5. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X, Dillehay LE, Williams JR, Shastri VR, Williams JA.
    Int J Cancer; 2001 Apr 20; 96(2):118-25. PubMed ID: 11291095
    [Abstract] [Full Text] [Related]

  • 6. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
    Doiron A, Yapp DT, Olivares M, Zhu JX, Lehnert S.
    Cancer Res; 1999 Aug 01; 59(15):3677-81. PubMed ID: 10446981
    [Abstract] [Full Text] [Related]

  • 7. Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice.
    Cardinale RM, Dillehay LE, Williams JA, Tabassi K, Brem H, Lee DJ.
    Radiat Oncol Investig; 1998 Aug 01; 6(2):63-70. PubMed ID: 9572682
    [Abstract] [Full Text] [Related]

  • 8. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG, Williams JA, Tabassi K, Tyler BM, Babel KM, Anderson RC, Pinn ML, Brat DJ, Brem H.
    Cancer Res; 1996 Nov 15; 56(22):5217-23. PubMed ID: 8912860
    [Abstract] [Full Text] [Related]

  • 9. Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma.
    Williams JA, Yuan X, Dillehay LE, Shastri VR, Brem H, Williams JR.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):631-9. PubMed ID: 9806525
    [Abstract] [Full Text] [Related]

  • 10. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
    Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H.
    Cancer Res; 1994 Apr 15; 54(8):2207-12. PubMed ID: 7909720
    [Abstract] [Full Text] [Related]

  • 11. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV, Bloomer WD, Hollingshead MG.
    Anticancer Res; 2005 Apr 15; 25(3B):1865-9. PubMed ID: 16158918
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S, Romeike BF, Lehmann T, Israel I, Rübe C, Mautes A, Reiners C, Kirsch CM.
    J Nucl Med; 2009 Dec 15; 50(12):2025-32. PubMed ID: 19910430
    [Abstract] [Full Text] [Related]

  • 13. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE, Feola J, Houchens DP, Ovejera AA.
    Cancer Res; 1982 Mar 15; 42(3):812-6. PubMed ID: 7059979
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H.
    Cancer Res; 1994 Feb 15; 54(4):1008-15. PubMed ID: 8313355
    [Abstract] [Full Text] [Related]

  • 15. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P, Hanes J, DiMeco F, Tyler BM, Brat D, Pardoll DM, Brem H.
    Cancer Res; 1999 May 01; 59(9):2107-14. PubMed ID: 10232596
    [Abstract] [Full Text] [Related]

  • 16. Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.
    McKeown SR, Friery OP, McIntyre IA, Hejmadi MV, Patterson LH, Hirst DG.
    Br J Cancer Suppl; 1996 Jul 01; 27():S39-42. PubMed ID: 8763843
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ.
    Clin Cancer Res; 2000 Jun 01; 6(6):2513-20. PubMed ID: 10873107
    [Abstract] [Full Text] [Related]

  • 18. Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers.
    Yuan X, Fahlman C, Tabassi K, Williams JA.
    Cancer Biother Radiopharm; 1999 Jun 01; 14(3):177-86. PubMed ID: 10850302
    [Abstract] [Full Text] [Related]

  • 19. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):493-8. PubMed ID: 16563655
    [Abstract] [Full Text] [Related]

  • 20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.